Moleculin Biotech, Inc. announced the appointment of Joy Yan, M.D., Ph.D. to its Board of Directors. Joy Yan, M.D., Ph.D., currently serves as an Independent Board Director at Checkmate Pharmaceuticals. She is also a member of the Scientific Advisory Board at Ambrx, after her role as the Chief Medical Officer, where she led the pipeline strategy and quickly advanced the development programs.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.92 USD | +1.44% | +4.68% | -61.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.79% | 10.96M | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.84% | 22.27B | |
-12.64% | 22.22B | |
-4.59% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- Moleculin Biotech, Inc. Announces Appointment of Joy Yan, M.D., Ph.D. to Board of Directors